微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 25.03% | -0.42% | 0.74% | 113/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 24.84% | 7.7% | 2.32% | 116/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 24.28% | 6.11% | 0.48% | 115/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 24.16% | 6.91% | -3.85% | 117/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 25.13% | 2% | 8.96% | 112/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 23.07% | 1.03% | 0.81% | 117/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 22.88% | 2% | 1.23% | 112/139 | 53.23% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 22.6% | 0.3% | -0.99% | 115/139 | 53.35% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 22.83% | -5.47% | 1.31% | 118/139 | 53.18% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-06-30 | 22.54% | 2.43% | -6.7% | 115/139 | 53.47% | 正海生物 | 89.9% | 行业排名> |
| 2022-12-31 | 24.15% | 2.31% | 9.78% | 116/139 | 53.71% | 正海生物 | 90.39% | 行业排名> |
| 2022-06-30 | 22% | 2% | -6.81% | 117/139 | 54.84% | 正海生物 | 90.3% | 行业排名> |
| 2021-12-31 | 23.61% | -48.75% | -48.75% | 120/139 | 57.28% | 正海生物 | 89.78% | 行业排名> |
| 2020-12-31 | 46.06% | 99.21% | 99.21% | 98/139 | 59.49% | 三友医疗 | 90.18% | 行业排名> |
| 2019-12-31 | 23.12% | 2% | 2% | 111/139 | 56.29% | 三友医疗 | 90.14% | 行业排名> |